BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22189417)

  • 1. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
    Urbonas V; Eidukaitė A; Tamulienė I
    Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
    Urbonas V; Eidukaitė A; Tamulienė I
    Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-8 predicts pediatric oncology patients with febrile neutropenia at low risk for bacteremia.
    Cost CR; Stegner MM; Leonard D; Leavey P
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):206-11. PubMed ID: 23425997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of interleukin-6 and interleukin-8 for early prediction of bacteremia and sepsis in children with febrile neutropenia and cancer.
    Urbonas V; Eidukaitė A; Tamulienė I
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):122-7. PubMed ID: 22367386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of bacteremia in febrile neutropenic episodes in children with cancer: microbiologic and molecular approach.
    Santolaya ME; Farfán MJ; De La Maza V; Cociña M; Santelices F; Alvarez AM; Avilés CL; Becker A; O'Ryan M; Román P; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Torres JP
    Pediatr Infect Dis J; 2011 Nov; 30(11):957-61. PubMed ID: 21768922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
    Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
    Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary tract infections in pediatric oncology patients with fever and neutropenia.
    Sandoval C; Sinaki B; Weiss R; Munoz J; Ozkaynak MF; Tugal O; Jayabose S
    Pediatr Hematol Oncol; 2012 Feb; 29(1):68-72. PubMed ID: 22304012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
    Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
    Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk.
    Diepold M; Noellke P; Duffner U; Kontny U; Berner R
    BMC Infect Dis; 2008 Mar; 8():28. PubMed ID: 18321393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between protein C levels and bacteremia in children with febrile neutropenia.
    Kassam A; Chan AK; Dzolganovski B; Constantin J; Ramphal R; Grant R; Sung L
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):647-50. PubMed ID: 19644401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6, interleukin-8, interleukin-10, and C-reactive protein in febrile neutropenia in children with malignant diseases.
    Spasova MI; Terzieva DD; Tzvetkova TZ; Stoyanova AA; Mumdzhiev IN; Yanev IB; Genev ED
    Folia Med (Plovdiv); 2005; 47(3-4):46-52. PubMed ID: 16761394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode.
    Santolaya ME; Alvarez AM; Avilés CL; Becker A; Mosso C; O'Ryan M; Payá E; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
    Pediatr Infect Dis J; 2007 Sep; 26(9):794-8. PubMed ID: 17721373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
    de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
    Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children.
    Stryjewski GR; Nylen ES; Bell MJ; Snider RH; Becker KL; Wu A; Lawlor C; Dalton H
    Pediatr Crit Care Med; 2005 Mar; 6(2):129-35. PubMed ID: 15730597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of interleukin-5 and monocyte chemotactic protein-1 for bacteremia in children with febrile neutropenia.
    Aquino VM; Cost C; Gomez A; Bowers DC; Ramilo O; Ahmad N; Winick N; Leavey PJ
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):e241-5. PubMed ID: 22584776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8 serum levels at fever onset in patients with neutropenia predict early medical complications.
    Engel A; Knoll S; Kern P; Kern WV
    Infection; 2005 Oct; 33(5-6):380-2. PubMed ID: 16258872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.
    Baorto EP; Aquino VM; Mullen CA; Buchanan GR; DeBaun MR
    Cancer; 2001 Aug; 92(4):909-13. PubMed ID: 11550165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia.
    Giamarellos-Bourboulis EJ; Grecka P; Poulakou G; Anargyrou K; Katsilambros N; Giamarellou H
    Clin Infect Dis; 2001 Jun; 32(12):1718-25. PubMed ID: 11360214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
    Avabratha KS; Rau AT; Venkataravanamma P; Rau A
    Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.